BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: El-Komy MH, Widness JA, Veng-Pedersen P. Pharmacokinetic analysis of continuous erythropoietin receptor activator disposition in adult sheep using a target-mediated, physiologic recirculation model and a tracer interaction methodology. Drug Metab Dispos 2011;39:603-9. [PMID: 21209249 DOI: 10.1124/dmd.110.036236] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Bach T, Jiang Y, Zhang X, An G. General Pharmacokinetic Features of Small-Molecule Compounds Exhibiting Target-Mediated Drug Disposition (TMDD): A Simulation-Based Study. The Journal of Clinical Pharmacology 2019;59:394-405. [DOI: 10.1002/jcph.1335] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
2 El-Komy MH, Schmidt RL, Widness JA, Veng-Pedersen P. Differential pharmacokinetic analysis of in vivo erythropoietin receptor interaction with erythropoietin and continuous erythropoietin receptor activator in sheep. Biopharm Drug Dispos 2011;32:276-88. [PMID: 21678432 DOI: 10.1002/bdd.757] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
3 Locatelli F, Del Vecchio L. Erythropoiesis-stimulating agents in renal medicine. Oncologist 2011;16 Suppl 3:19-24. [PMID: 21930831 DOI: 10.1634/theoncologist.2011-S3-19] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
4 An G, Liu W, Dutta S. Small-molecule compounds exhibiting target-mediated drug disposition - A case example of ABT-384: Small-Molecule Compounds Exhibiting Target-Mediated. The Journal of Clinical Pharmacology 2015;55:1079-85. [DOI: 10.1002/jcph.531] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
5 An G. Concept of Pharmacologic Target-Mediated Drug Disposition in Large-Molecule and Small-Molecule Compounds. J Clin Pharmacol 2020;60:149-63. [PMID: 31793004 DOI: 10.1002/jcph.1545] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
6 Schmid H. Methoxy polyethylene glycol-epoetin beta for the treatment of anemia associated with chronic renal failure. Expert Rev Hematol 2016;9:5-20. [PMID: 26573694 DOI: 10.1586/17474086.2016.1112734] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
7 An G. Small-Molecule Compounds Exhibiting Target-Mediated Drug Disposition (TMDD): A Minireview. J Clin Pharmacol 2017;57:137-50. [PMID: 27489162 DOI: 10.1002/jcph.804] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
8 Sun J, Michaels M. Novel Constructs—Half-Life Extensions. In: Warne NW, Mahler H, editors. Challenges in Protein Product Development. Cham: Springer International Publishing; 2018. pp. 527-44. [DOI: 10.1007/978-3-319-90603-4_23] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]